
- BioPharm International-05-15-2021
- Volume 2021 eBook
- Issue 2
CDMO Landscape Seeing Changes as Consolidation Continues
The expected growth of the global bio/pharmaceutical market is pushing for the continued evolution of the CDMO arena.
Consolidation in the contract manufacturing landscape in recent years has resulted in service providers that now have varied scientific, technical, and technology expertise. The ability to provide real-time data analytics is in high demand, and there is a need for innovative flow filtration technologies, factors that seem to be driving some of this consolidation.
About the author
Feliza Mirasol is the science editor for BioPharm International.
Article Details
BioPharm International
eBook: Partnerships for Outsourcing, May 2021
May 2021
Pages: 4–6
Citations
When referring to this article, please cite it as F. Mirasol, “CDMO Landscape Seeing Changes as Consolidation Continues," BioPharm International Partnerships for Outsourcing eBook (May 2021).
Articles in this issue
about 5 years ago
RNA’s Expanding Horizonsabout 5 years ago
Challenges When Outsourcing Viral Safety Servicesabout 5 years ago
Ensuring Contract Manufacturing Facilities Are Up to Speedabout 5 years ago
Succeeding with Remote Auditsabout 5 years ago
Demystifying Complex Clinical Trial Kit Prepabout 5 years ago
CDMO Partnerships Boost Company Capabilities


